Edition:
United Kingdom

Caladrius Biosciences Inc (CLBS.OQ)

CLBS.OQ on NASDAQ Stock Exchange Capital Market

3.61USD
20 Mar 2019
Change (% chg)

$-0.26 (-6.72%)
Prev Close
$3.87
Open
$3.83
Day's High
$3.83
Day's Low
$3.59
Volume
4,914
Avg. Vol
6,172
52-wk High
$11.65
52-wk Low
$3.15

Select another date:

Mon, Oct 22 2018

BRIEF-Roche Says Phase III Study On Alecensa Meets Primary Endpoint

* SAYS WILL TO ANNOUNCE RESULTS FROM THE PHASE III ALESIA STUDY, SHOWING THAT ALECENSA® (ALECTINIB) MET ITS PRIMARY ENDPOINT OF INVESTIGATOR-ASSESSED (INV) PROGRESSION-FREE SURVIVAL (PFS)

Select another date: